New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
07:26 EDTTHORImpact of Thoratec notice limited , says Oppenheimer
After Thoratec announced a worldwide urgent correction in order to update its labeling and training materials for the HeartMate II Pocket Controller, Oppenheimer says that the correction is not product related. The firm assumes the company does not need to take additional steps, and added that the notice is not expected to have a material financial impact on the company. The firm keeps a $45 price target and Outperform rating on the stock.
News For THOR From The Last 14 Days
Check below for free stories on THOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
11:41 EDTTHORLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
September 15, 2014
07:21 EDTTHORHeart Failure Society of America to hold annual meeting
Subscribe for More Information
September 9, 2014
16:46 EDTTHORThoratec announces start of Heartmate III U.S. clinical trial
Subscribe for More Information
September 4, 2014
10:01 EDTTHORThoratec management to meet with Oppenheimer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use